SHR0302 tablets

SHR0302 · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR0302 tablets, covering 2021-09-30 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo [Phase 2]